JAPROLOX Patch Ref.[49536] Active ingredients: Loxoprofen

Revision Year: 2019  Publisher: <u>Manufacturer:</u> Lead Chemical Co., Ltd., Hisagane Plant, 327 Hisagane Kamiichi-machi Nakaniikawa-gun, Toyama, Japan <u>Importer and marketing authorization holder:</u> ZUELLIG PHARMA LTD., Bangkok, ...

4.3. Contraindications

Loxoprofen sodium patch is contraindicated in the following patients.

  • Patients with a history of hypersensitivity to any ingredients of Loxoprofen sodium patch.
  • Patients with or with a history of aspirin-induced asthma (induction of asthmatic attack with nonsteroidal anti-inflammatory-analgesics, etc.) [May induce an aspirin- induced asthmatic attack.]

4.4. Special warnings and precautions for use

Careful Administration

Loxoprofen sodium patch should be administered with caution in the following patients: Patients with bronchial asthma (as the disease state may be exacerbated.)

Clinically Significant Adverse Reactions

Shock, anaphylaxis: Shock or anaphylaxis (decreased blood pressure, urticaria, laryngeal oedema, dyspnoea, etc.) may occur. Patients should be carefully monitored. If any abnormalities are observed, use of this drug should be discontinued immediately and appropriate measures should be taken."

Important Precautions

  • It is important to note that treatment with anti-inflammatory- analgesic agents is a symptomatic treatment, not a causal treatment.
  • For treatment of skin inflammation caused by infectious disease, Loxoprofen sodium patch may cause a risk of masking the signs and symptoms of the infectious disease, therefore, the appropriate antibacterial and/or antifungal drugs must be administered in combination with Loxoprofen sodium patch to the affected part of the skin, under careful observation and caution.
  • Therapies other than drug treatment must also be considered in using Loxoprofen sodium patch in the management of chronic diseases (osteoarthritis and others). The patient’s clinical condition should be closely monitored with caution against the development of adverse reactions.
  • Avoid using this drug in people with bleeding in the stomach, intestines or ulcers. Since this drug increases the risk of developing these symptoms.
  • Avoid using in people with liver disease or kidney disease or abnormal liver function or kidney function.
  • This drug, if used continuously for a long time, may produce adverse reactions, such as oral medication, such as the risk of platelet abnormalities or disorders of the cardiovascular system.

Use in the Elderly

Loxoprofen sodium patch should be used with careful monitoring of dermal condition of application area, in the elderly patients.

Pediatric Use

The safety of Loxoprofen sodium patch in low birth weight infants, newborn infants, infants and toddlers, children and adolescents has not been established (because there has been little experience of its use in pediatric patients).

Precautions Concerning Use

Site of application:

  • Do not apply Loxoprofen sodium patch onto area of damaged or non-intact skin or mucosal membrane.
  • Do not apply Loxoprofen sodium patch onto area of eczema and rash.

4.5. Interaction with other medicinal products and other forms of interaction

Not applicable to both contraindications and precautions for coadministration.

4.6. Pregnancy and lactation

Loxoprofen sodium patch should be administered to women who are or are possibly pregnant only when the anticipated therapeutic benefits are considered to outweigh any potential risk. [The safety of Loxoprofen sodium patch in these populations has not been established.]

It has been reported that constriction of the fetal ductus arteriosus is observed when woman in the late stage of pregnancy received other nonsteroidal anti-inflammatory analgesic drugs for external use.

4.7. Effects on ability to drive and use machines

There is no data available on effects on ability to drive and use machines.

4.8. Undesirable effects

 0.5% to <3% <0.5% Incidence unknown
Hypersensitivity Pruritus,
erythema,
contact dermatitis,
rash
Haemorrhage
subcutaneous,
skin irritation,
pigment precipitation
Blister,
swelling
Gastrointestinal  Stomach discomfort,
upper abdominal pain,
diarrhea,
loose stools
 
Hepatic  Increased AST,
increased ALT,
increased γ−GTP
 
Other  Edema 

6.2. Incompatibilities

No applicable data is available.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.